Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Build a Winning Medical Device Commercial Strategy

Integrated evidence, market insight, and reimbursement know-how turn your breakthrough into standard of care, accelerating medical device & IVD commercialization worldwide.

Supercharge Medical Device Commercial Strategy with Veranex Experts


Your medical device commercial strategy lives or dies on mastering the unique interplay of engineering, evidence, and reimbursement. Our medtech-seasoned team speaks FDA 510(k)-PMA and EU-MDR-IVDR, decodes DRG and CPT pathways, and converts clinician insights into value claims that speed adoption. Engage us pre-concept to validate market need, embed health economic endpoints into planned studies, or post-clearance to energize launch—flexibly bolting onto your workflow and amplifying medical device commercialization success.

Services Overview

Our Five Pillars of Medical Device Commercialization Success

Think of these five pillars as an interconnected flywheel, each amplifies the next. Innovation Strategy pinpoints the right market, Reimbursement & Market Access clears a payment runway, while Market & Customer Insights sharpen positioning. HEOR models then translate clinical value into economic proof, and Integrated Evidence Planning stitches it all together with clinical and regulatory insights included.

The result: a seamless medical device commercial strategy that accelerates adoption, protects price, and fuels long-term growth from concept through post-launch.

Innovation Strategy & M&A

Innovation Strategy & M&A

De-risk build-buy-partner moves with data-driven assessment of R&D and commercial opportunity and fit analyses.

Learn more

csma-1

Reimbursement & Market Access

Reimbursement & Market Access

Identify needed codes, evidence to secure coverage, and payment levers early—accelerating clinical adoption and payer acceptance.

Learn more

csma-2

Market & Customer Insights

Market & Customer Insights

Voice-of-stakeholder research pinpoints unmet needs and adoption drivers across clinicians, payers, purchasers, and patients.

Learn more

csma-3

HEOR Consulting

HEOR Consulting

Health-economic models quantify budget impact or cost-effectiveness—arming you with value dossiers that win formulary decisions.

Learn more

csma-4

Integrated Evidence Planning

Integrated Evidence Planning

Seamlessly align clinical, economic, and real-world data generation to demonstrate value and accelerate regulatory approval, clinical adoption and payer coverage.

Learn more

csma-5

Turn Strategy into Sales Velocity, Start Today

Partner with Veranex to unlock payer and purchaser access, market uptake, and sustained growth. Let’s architect your medical device commercial strategy and launch smarter and deliver value faster.